Question 4

6/5/2017

/Templates/Article.aspx?id=4294980080

Question 6

6/5/2017

/Templates/Article.aspx?id=4294980082

Question 1

6/5/2017

/Templates/Article.aspx?id=4294980077

Question 3

6/5/2017

/Templates/Article.aspx?id=4294980079

Treating Hearing Impaired Patients Evaluation - DO NOT USE

6/5/2017

/Continuing-Education-and-Events/Online-CME/Courses/Legal-Advisor--Treating-Hearing-Impaired-Patients-under-the-Americans-with-Disabilities-Act/Treating-Hearing-Impaired-Patients-Evaluation---DO-NOT-USE/

Question 2

6/5/2017

/Templates/Article.aspx?id=4294980078

Disclosure, Apology and Offer Exam

6/5/2017

/Templates/CME/Exam.aspx?id=4294980045

Disclosure, Apology and Offer Evaluation - DO NOT USE

6/5/2017

/Templates/CME/Exam.aspx?id=4294980055

Understanding Supervised Injection Facilities

6/5/2017

Download Interactive PDF (2 pages)  The MMS has been engaged for several years in efforts to address the opioid misuse epidemic. Recognizing that physicians must be an important part of the solution to this epidemic, the MMS formed a Task Force on Opioid Prescribing and Physician Communication in 2014. One

/Advocacy/Key-Issues/Substance-Use-Disorder-and-the-Opioid-Crisis/Understanding-Supervised-Injection-Facilities/

About Supervised Injection Facilities (SIFs)

6/5/2017

/Advocacy/Key-Issues/Substance-Use-Disorder-and-the-Opioid-Crisis/About-Supervised-Injection-Facilities-(SIFs)/